ClinVar Miner

Submissions for variant NM_004380.3(CREBBP):c.1823T>C (p.Leu608Pro)

dbSNP: rs2053254528
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV001249727 SCV001423755 likely pathogenic Rubinstein-Taybi syndrome due to CREBBP mutations 2020-03-02 criteria provided, single submitter clinical testing The CREBBP c.1823T>C (p.Leu608Pro) variant is a missense variant. A literature search was performed for the gene, cDNA change and amino acid change. No publications were found based on this search. This variant is not found in the Genome Aggregation Database in an area of good sequence coverage and is therefore presumed to be rare. The Leu608 residue is located in the KIX domain of CREBBP, a binding site for transcriptional activators (Wood et al. 2016). Based on the de novo origin of the variant and its rarity, the p.Leu608Pro variant is classified as likely pathogenic for Rubinstein-Taybi syndrome.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.